Specialised Therapeutics' chronic graft-versus-host disease therapy approved in Australia
Telix Pharmaceuticals' MAA for TLX101-Px (Pixlumi) accepted for European review
Bambusa Therapeutics completes patient enrolment in Phase 1b/2a trial for atopic dermatitis
Lab Thread launches unified digital platform for biological research workflows
Curocell secures full approval for RIMQARTO to enter CAR-T therapy market
Precision Biosciences initiates patient enrollment in PBGENE-DMD clinical study
Immunome submits FDA application for varegacestat following strong Phase 3 results
HUTCHMED secures priority review for sovleplenib NDA in China
Chiesi Group to acquire KalVista Pharmaceuticals for USD1.9bn in rare disease expansion strategy
Circio partners with USC to advance non-viral RNA delivery technologies
Cirius Therapeutics introduces gestational diabetes initiative
Vanda Pharmaceuticals reports publication of imsidolimab phase III findings in NEJM Evidence